MI Medical Innovation GmbH

Company | Germany

About your organization

MI Medical Innovation GmbH (MI) is a medical device systems concept company, Horizon 2020 SME Instrument Phase 1 champion, especially for hemodynamic monitoring, collaborating mainly with emka MEDICAL (emka-medical.de), at the same location with EU-MDD- Annex-II.3 certificate for sterile and non-sterile pressure transducers and software for display of physiological parameters, with ISO 13485:2016 certificate for more, also temperature, oxygen and lactate sensors, dataloggers, and the scope as in Annex II.3 to bring heart failure monitoring systems to the market.

Cor/log Implant, our novel implantable hemodynamic monitoring system for cardiovascular diseases, is a product family consisting of two product types, semi-impant and full implant. The 1P2O version is awarded with Horizon 2020 SME Instrument Phase 1 grant, with the Phase 2 clinical validation awarded with the Seal of Excellence from EU. Cor/log Implant 1P2O monitors venous pressure, venous oxygen and right atrial oxygen.

News

Chunnan Chen

Published 5 years ago

The first product of the one pressure (1P) version, Cor/log Probe-1P is coming soon to the market

The first product of the one pressure (1P) version, Cor/log Probe-1P is coming soon to the market by emka MEDICAL (emka-medical.de), with CE, for both inpatient and outpatient venous pressure monitoring. The first application is functional monitoring of tricuspid valve repair or replacement, which further followed by heart failure monitoring, based on the validated biomarker (by Abbott) pulmonary artery pressure (PAP). Oxygen sensing will come next to evaluate from the coronary sinus the metabolic conditions of the left heart.